Dejac-T 4Tablets

babies: not applicable. lactating mother: consult your doctor before using this medication during breastfeeding. pregnancy: consult your doctor before using this medication during pregnancy. alcohol: it is not safe to drink alcohol with tadalafil, dapoxetine tablet. driving: tadalafil, dapoxetine tablet may cause dizziness and sleepiness, affecting your ability to drive. do not drive if these symptoms occur. kidney: tadalafil, dapoxetine tablet to be used with caution in patients with kidney disease.
dose adjustment is required. consult your doctor. liver: tadalafil, dapoxetine tablet to be used with caution in patients with liver disease.
dose adjustment is required. consult your doctor..

Nausea Vomiting Indigestion Headache Flushing Dizziness Nosebleeds Dryness in mouth.

Tadalafil in DEJAC T Tablets is a phosphodiesterase type 5 inhibitor. It acts by blocking the phosphodiesterase enzyme, which results in an increased blood flow to the penis.
Dapoxetin is a selective serotonin reupTake inhibitor. It enhances the serotonin level in nerves, improving control over ejection and increasing the time taken to ejaculate..

If you miss a dose, Take it as soon as possible. If It is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• You have to take this tablet 1 to 3 hours Before sex • Avoid driving after taking this medication because It may cause excessive drowsiness • Inform your doctor If you have a previous history of heart attack, stroke, and heart failure • It may cause low blood pressure, so Get up slowly from the sitting and lying position..

• tadalafil + amyl nitrite: concurrent use may result in potentiation of hypotensive effects • tadalafil + riociguat: concurrent use may result in an increased risk of hypotension • tadalafil + atazanavir: concurrent use may result in increased tadalafil bioavailability • tadalafil + erythromycin: concurrent use may result in increased tadalafil bioavailability • tadalafil + simvastatin: concurrent use may result in an increased risk of myopathy • dapoxetine + abametapir: concurrent use may result in increased serum concentration of dapoxetine • dapoxetine + abatacept: concurrent use may result in increased metabolism of dapoxetine • dapoxetine + acarbose: concurrent use may result in an increased risk of hypoglycemia. • dapoxetine + ancord: concurrent use may result in an increased risk of hemorrhage.